Gilead Sciences, a research-based biopharmaceutical company, discovers, develops and commercializes innovative medicines in areas of unmet need. Gilead’s primary areas of focus include liver disease, HIV/AIDS, serious cardiovascular, metabolic and respiratory conditions, oncology and inflammation. With each new discovery and experimental drug candidate, we seek to improve the care of patients suffering from life-threatening diseases. Founded in 1987 in Foster City, California, Gilead employs over 4,000 people worldwide. As Gilead grows, so do our responsibilities as a corporate citizen. Today, the Gilead Access Program supports access to our HIV and HBV treatments at substantially reduced prices in resource limited countries.

 

We have been at the forefront of the global response to the HIV and AIDS epidemic for more than 25 years. Our scientists were among the first to discover and develop medicines  for HIV, and today we continue  with our commitment to address the impact of this disease on patients, their families and carers.

Our therapies in the area of infectious disease also include medicines for the treatment of Hepatitis C, a disease that affects approximately 130 to 170 million people globally and an estimated  200,000 in the UK, with many unaware and undiagnosed until chronic symptoms arise. Further research, awareness, education, early diagnosis and effective management for both these conditions remain our focus. We work with the NHS, academics and non-governmental organisations to achieve these goals.

ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline and Pfizer dedicated to delivering advances in treatment and care for people living with HIV. The company’s aim is to take a deeper and broader interest in HIV/AIDS than any company has done before and take a new approach to deliver effective and new HIV medicines as well as support communities affected by HIV. For more information on the company, its management, portfolio, pipeline and commitment, please visit www.viivhealthcare.com.